NCT06382987View on ClinicalTrials.gov

A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Plaque Psoriasis
Interventions
DRUG

Deucravacitinib

According to the product label

DRUG

Apremilast

According to the product label

Trial Locations (2)

1070052

RECRUITING

Mebix. Inc., Minato-ku

Unknown

RECRUITING

Fukuoka University Hospital, Fukuoka

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY